{"slideshow_credits": null, "snippet": "The data suggested that Vertex could have a multibillion-dollar franchise in treating cystic fibrosis, a life-threatening genetic disorder that affects about 70,000 people worldwide.", "abstract": "Vertex Pharmaceuticals says preliminary findings shows its combination of a cystic fibrosis drug and an experimental treatment for the disease led to significantly improved breathing ability for patients; data suggests Vertex could have a multibillion-dollar franchise in treating the disease.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/05/08/business/vertexs-cystic-fibrosis-therapy-is-called-game-changing.html", "lead_paragraph": "The data suggested that Vertex could have a multibillion-dollar franchise in treating cystic fibrosis, a life-threatening genetic disorder that affects about 70,000 people worldwide.", "headline": {"seo": "Vertex&#8217;s Cystic Fibrosis Therapy Is Called &#8216;Game-Changing&#8217;", "main": "A Cystic Fibrosis Treatment Is Called &#8216;Game-Changing&#8217;", "print_headline": "A Cystic Fibrosis Treatment Is Called \u2018Game-Changing\u2019"}, "_id": "53a97dfc38f0d85886bc4062", "word_count": "636", "multimedia": [], "pub_date": "2012-05-08T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Vertex Pharmaceuticals Inc", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Cystic Fibrosis", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "News"}